share_log

Craig-Hallum Maintains Buy on BioLife Solns, Raises Price Target to $30

Benzinga ·  Aug 13 01:21  · Ratings

Craig-Hallum analyst Matt Hewitt maintains BioLife Solns (NASDAQ:BLFS) with a Buy and raises the price target from $23 to $30.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment